PART2: Circulating Tumor Cells as Biomarkers in Clinical Development - Introductory Course. Metastasis and Circulating Tumor Cells (CTCs): discussion of metastasis and how CTCs disseminate. Analysis of CTCs: how CTCs are captured and analyzed. CTCs as biomarkers: predictive and prognostic characteristics. CTCs in oncology clinical studies: discussion of several seminal scientific reports and implementation of CTCs in biomarker studies related to oncology drug development. Instructor: Dr. Alexander Kuklin. (October, 2010)
Showing a sample of a course we offer from the BioPharma Institute. Part II
biopharmainstitute 4 months ago